For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
220.7 ZAR | +1.98% | +1.70% | +8.46% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.
For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
220.7 ZAR | +1.98% | +1.70% | 5.22B | ||
146.1 USD | -0.46% | -1.20% | 352B | ||
1st Jan change | Capi. | |
---|---|---|
+8.46% | 5.22B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
-4.29% | 4.71B |